Benzinga - Fri, 24 Jul 2020 04:19:47 -0400
Sector: Health Care.Industry: Pharmaceuticals
Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the major pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-04-23
REV
Q4 2020Est.ActualSurprise
EPS0.090
REV210.174M

Related Companies

TickerCompanyChg %Mkt Cap
HYPMYHypera3.9%3.9B

Hypera Company Questions & Answers

Q

How do I buy Hypera (HYPMY) stock?

A

You can purchase shares of Hypera (OTC: HYPMY) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Hypera's (HYPMY) main competitors?

A

There are no as such competitors for Hypera.

Q

What is the target price for Hypera?

A

There is no analysis for Hypera

Q

How much is Hypera (HYPMY) stock ?

A

The stock price for Hypera (OTC: HYPMY) is $6.13 last updated Mon Apr 12 2021 20:00:01 GMT+0000 (Coordinated Universal Time).

Q

When is the next Hypera (HYPMY) dividend?

A

There are no upcoming dividends for Hypera. The last dividend paid out to investors was $0.03 on 2018-10-04.

Q

When is Hypera (OTC:HYPMY) reporting earnings?

A
Hypera’s Q1 earnings are confirmed after-market from now on April 23, 2021.
Q

When is the upcoming split for HYPMY?

A

There is no upcoming split for Hypera.